Full Text View
Tabular View
No Study Results Posted
Related Studies
The Effects of Tegaserod Vs. Placebo on Whole Gut Transit Time in Patients With Chronic Constipation and Dyspepsia
This study has been withdrawn prior to recruitment.
Study NCT00277550   Information provided by Novartis
First Received: January 13, 2006   Last Updated: September 7, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Constipation and Dyspepsia
Additional conditions recognized in this trial
Constipation
Dyspepsia
More general conditions related to this trial
Signs and Symptoms
Signs and Symptoms, Digestive
Interventions listed in this trial
Tegaserod and Placebo
Additional drug interventions recognized in this trial
Tegaserod
More general drug interventions related to this trial
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Serotonin Agents
Serotonin Agonists
Sponsors listed in this trial
Novartis
Mayo Clinic


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services